Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) (347499)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: Oct 17, 2023 (Full proposal)

Later deadlines: May 13, 2024 (Letter of inquiry), May 13, 2024 (Full proposal), Sep 17, 2024 (Letter of inquiry), Oct 17, 2024 (Full proposal)

Grant amount: Up to US $275,000

Fields of work: Rare Diseases

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: United States, American Samoa, Northern Mariana Islands, Puerto Rico, Virgin Islands

Location of residency: United States, American Samoa, Northern Mariana Islands, Puerto Rico, Virgin Islands

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization. 

This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

This page was last reviewed April 17, 2023 and last updated April 17, 2023